FIELD: immunology.
SUBSTANCE: invention relates to immunology, which can be used in clinical practice to assess the viability of peripheral blood lymphocytes of the body, in particular to a method for assessing the functional state of peripheral blood lymphocytes. The method includes: taking blood from animals immediately after delivery from the jugular vein, dividing it into plasma, conducting a study of peripheral blood lymphocytes by complement-dependent cytotoxicity in a two-stage exposure first to immune autologous serum containing antibodies, and then to complement. At the same time, lymphocytes with low functional activity are subjected to a cell lysis reaction, established by the penetration of a lifetime dye into the cell, and the percentage of lysis of lymphocytes is determined by the intensity of the reaction.
EFFECT: use of the invention provides an increase in the reliability of a laboratory study of the assessment of the functional state of peripheral blood lymphocytes in animals.
1 cl, 2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF GLUCOCORTICOSTEROID CLINICAL EFFECTIVENESS | 2008 |
|
RU2382364C1 |
METHOD FOR ASSESSING FUNCTIONAL STATE OF HUMAN LYMPHOCYTE | 2013 |
|
RU2543340C2 |
METHOD FOR PREDICTION OF PATIENT'S IMMUNE RESPONSE TO ENVIRONMENTAL EXPOSURE | 2012 |
|
RU2543336C2 |
METHOD OF in vitro ESTIMATING INDIVIDUAL REACTION OF PATIENT'S ORGANISM TO ACTION OF PHARMACOLOGICAL PREPARATION | 2012 |
|
RU2526134C2 |
METHOD FOR DETERMINING DEGREE OF T-LYMPHOCYTE ENERGISING | 2014 |
|
RU2577118C1 |
DIAGNOSTIC METHOD FOR RENAL ALLOGRAFT REJECTION | 2007 |
|
RU2348932C1 |
METHOD OF LEOKOSIS COURSE PROGNOSIS | 1991 |
|
RU2069858C1 |
PHARMACEUTICAL COMPOSITION FOR INDUCING OF IMMUNE RESPONSE IN HUMAN | 2002 |
|
RU2313365C2 |
METHOD DETERMINING SPONTANEOUS CELL CYTOTOXICITY | 2001 |
|
RU2208786C1 |
METHOD FOR DETERMINATION OF INDIVIDUAL SENSITIVITY TO IMMUNOMODULATOR | 0 |
|
SU1658094A1 |
Authors
Dates
2022-01-11—Published
2021-02-15—Filed